Theme #3: Transfusion Safety

#The Goal

We aim to improve appropriate transfusion practice utilization across Canada by implementing evidence-based transfusion care and patient blood management into clinical transfusion practice.

#Publications

  1. Parmar N, Pendergrast J, Lieberman L, Lin Y, Callum J, Cserti-Gazdewich C. The association of fever with transfusion-associated circulatory overload. Vox Sang 2017;112:70-8. 
  2. Callum JL, Cohen R, Cressman AM, et al. Cardiac stress biomarkers after red blood cell transfusion in patients at risk for transfusion-associated circulatory overload: a prospective observational study. Transfusion 2018;58:2139-48. 
  3. Lin Y, Cohen R, Armali C, et al. Transfusion-associated circulatory overload prevention: a retrospective observational study of diuretic use. Vox Sang 2018;113:386-92. 
  4. Pendergrast J, Armali C, Cserti-Gazdewich C, et al. Can furosemide prevent transfusion-associated circulatory overload? Results of a pilot, double-blind, randomized controlled trial. Transfusion 2019;59:1997-2006. 
  5. Branch DR, Hellberg A, Bruggeman CW, et al. ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis. Blood 2018;131:830-5
  6. Callum J, Etchells E, Shojania K.  Addressing the identify crisis in healthcare: positive patient identification technology reduces wrong patients evnets. 2019. Transfusion. Mar;59(3):899-902. doi: 10.1111/trf.15160
  7. Ning S, Yan MTS, Downie H, Callum J. What's in a name? Patient registration errors and their threat to transfusion safety. Transfusion 2018 ;58:3035-6
  8. Strauss R, Downie H, Wilson A, et al. Sample collection and sample handling errors submitted to the transfusion error surveillance system, 2006 to 2015. Transfusion 2018;58:1697-707
  9. Cohen R, Ning S, Yan MTS, Callum J. Transfusion Safety: The Nature and Outcomes of Errors in Patient Registration. 2018. Transfus Med Rev
  10. Puga Yung G, Seebach JD, Baerenzung N, Pendergrast J, Cserti-Gazdewich C, Branch DR. Eluates from DAT-positive patients with or without hemolysis after high-dose IVIG yield predominantly IgG isoagglutinins of IgG2 subclass.  Transfusion 2019 [In press]
  11. Alam A, Cserti-Gazdewich C.  Perioperative management of an IgA-deficient recipient of a double lung transplant. Can J Anesth 2014 May; 61(5): 441-5.
  12. Alam A, Cserti-Gazdewich C, Pendergrast J.  The off-label utilization of prothrombin complex concentrate with cryoprecipitate as an alternative to plasma transfusion in bleeding patients with acute right ventricular failure. Can J Anaesth 2014 Mar; 61(3):284-6.
  13. Alam A, Huang M, Yi QL, Lin Y, Hannach B. Perioperative transfusion-related acute lung injury: The Canadian Blood Services experience. Transfusion Apheresis and Science. 2014 Apr 19;50(3):392-8
  14. Alam A, Lin Y, Lima A, Hansen M, Callum JL. The Prevention of Transfusion-Associated Circulatory Overload. Transfusion Medicine Reviews. 2013 Apr;27(2):105-12.
  15. Acker J, Yi Q-L, Cserti-Gazdewich C, Pendergrast J, Sondi N, Hannach B. Introduction of a Closed-System Cell Processor for Red Blood Cell Washing:  Post-Implementation Monitoring of Safety and Efficacy. Transfusion January 2016; 56(1):  49-57.
  16. Bloch EM, Sakac D, Branch HA, Cserti-Gazdewich C, Pendergrast J, Pavenski K, Branch DR.  Western immunoblotting as a new tool for investigating DAT negative autoimmune hemolytic anemias.  Transfusion 2015 Jun; 55(6Pt2): 1529-37.
  17. Branch DR.  Solving the dilemma of prevention of red cell alloimmunization.  Immunotherapy 4(9):903-905, 2012.
  18. Branch DR, Westhoff CM. Shining a light on AHG "blind" spot(s). Transfusion. 2016 Dec;56(12):2913-2915.
  19. Cheung D, Lieberman L, Lin Y, Callum J. Consent for blood transfusion: do patients understand the benefits and the risks? Transfusion Medicine. 2014 Jul 28;24(5):269-73. Epub 2014 Jul 28.
  20. Cohen R, Escorcia A, Lima A, Tasmin F, Lin Y, Lieberman L, Pendergrast J, Callum J, Cserti-Gazdewich C.  Feeling the Burn: The Significant Burden of Febrile Non-Hemolytic Transfusion Reactions. In press. Accepted 04 February 2017, Transfusion, TRANS-2016-0777.R2, doi 10.1111/trf.14099
  21. Cserti-Gazdewich C, Escorcia A, Pendergrast J, Lieberman L,  Skeate R, Lin Y, Callum J. Platelet Transfusion Reactions Do Not Occur More Often in Recipients Transfused With Apheresis versus Buffy Coat Platelet Concentrates.  Transfusion 2016 December; 56(12): 3144-3146.
  22. Jain MD, Cabrerizo-Sanchez R, Karkouti K, Yau T, Pendergrast J, Cserti-Gazdewich CM.  Seek and you shall find – but then what do you do?  Cold Agglutinins in Cardiopulmonary Bypass, and a Single Center Experience with Cold Agglutinin Screening Before Cardiac Surgery. Transfusion Medicine Reviews 2013: 27: 65-73.
  23. Keir A, Pal S, Trivella M, Lieberman L, Callum J, Shehata N, Stanworth SJ. Adverse effects of red blood cell transfusions in neonates: a systematic review and meta-analysis.  Transfusion 2016 Oct; 56 (11): 2773-2780.
  24. Keir A, Pal S, Trivella M, Lieberman L, Callum J, Shehata N, Stanworth S. Adverse effects of small-volume red blood cell transfusions in the neonatal population. Syst Rev. 2014 Aug 20;3:92.
  25. Keir AK, Hansen AL, Callum J, Jankov RP, Acker JP. Confusion of dextrose-containing fluids and red blood cells does not adversely affect in vitro red blood cell quality. Transfusion. 2014 Aug;54(8):2068-76.
  26. Keir A, Callum J, Jankov RP. Is it safe to co-infuse dextrose-containing fluids with red blood cells? J Paediatr Child Health. 2013 Aug;49(8):687-91.
  27. Keir A, Dunn M, Callum JL. Should intravenous immunoglobulin be used in infants with isoimmune haemolytic disease due to ABO incompatibility. Journal of Pediatrics and Child Health, Journal Club. 2013 Dec;49(12):1072-8.
  28. Kjaer M, Bertrand G, Bakchoul T, Massey E, Baker J, Lieberman L, Tanael S, Shehata N, Greinacher A, Murphy M, Arnold A, Baidya S, Bussel J, Kaplan C, Oepkes D, Ryan G, Kjeldsen-Kragh J. The detection of maternal human  platelet antigen 1a antibodies and their role in predicting the severity of fetal neonatal alloimmune thrombocytopenia: A Systematic Review.  American Journal of Obstetrics and Gynecology. Accepted Dec 2016.
  29. Kopolovic I, Ostro J, Tsubota H, Lin Y, Cserti-Gazdewich CM, Messner H, Keir AK, den Hollander N, Dzik W, Callum J.  CME Article: A Systematic Review of Reported Cases of Transfusion-Associated Graft Versus Host Disease (TA-GVHD): Determination of Patient and Blood Product-Related Risk Factors. Blood 16 July 2015; 126(3): 406-414.
  30. Lieberman L, Bercovitz RS, Sholapur NS, Heddle NM, Stanworth SJ, Arnold DM. Platelet Transfusions for Critically ill Patients with Thrombocytopenia. Blood. 2014 Feb 20;123(8):1146-51; quiz 1280.
  31. Lieberman L, Devine DV, Reesnik HW. Prevention of transfusion transmitted cytomegalovirus (CMV) infection: Standards of care. Vox Sang. 2014;107(3):276-311.
  32. Lieberman L, Liu Y, Portwine C, Barty RL, Heddle NM. An epidemiologic cohort study reviewing the practice of blood product transfusions among a population of pediatric oncology patients. Transfusion. 2014 Oct 1;54 (10 Pt 2):2736-44.
  33. Lieberman L, Maskens C, Cserti-Gazdewich C, Yi Q-L, Lin Y, Pendergrast J, Lima A, D’Onofrio L, Hansen M, Callum J.  A retrospective review of patient factors, transfusion practices, and outcomes in patients with Transfusion Associated Circulatory Overload (TACO).  Transfusion Medicine Reviews 2013 Oct; 27(4):206-12.
  34. Lin Y, Saskin A, Wells RA, Lenis M, Mamedov A, Callum J, Buckstein R. Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes. Vox Sanguinis 2017;112(1):79-86.
  35. Loza-Correa M, Kou Y, Taha M, Kalab M, Ronholm J, Schlievert PM, Cahill MP,  Skeate R, Cserti-Gazdewich C, Ramirez-Arcos S.  Septic Transfusion Case Caused by a Platelet Pool with Visible Clotting due to Contamination with Staphylococcus aureus. Transfusion 2017;57(5):1299-1303.
  36. Maskens C, Downie H, Wendt A, Lima A, Merkley L, Lin Y, Callum J. Hospital-based transfusion error tracking from 2005 to 2010: identifying the key errors threatening patient transfusion safety. Transfusion. 2014 Jan;54(1):66-73.
  37. Michelis FV, Branch DR, Scovell I, Bloch E, Pendergrast J, Lipton JH, Cserti-Gazdewich CM.  Acute hemolysis after intravenous immunoglobulin amid host factors of ABO-mismatched bone marrow transplantation, inflammation, and activated mononuclear phagocytes. Transfusion 2014 Mar; 54(3):681-90.
  38. Parmar N, Pendergrast J, Lieberman L, Lin Y, Callum J, Cserti-Gazdewich C.  The Association of Fever with Transfusion-Associated Circulatory Overload (TACO). Vox Sanguinis 2017 January; 112(1): 70-78.
  39. Sholzberg M, Pavenski K, Shehata N, Cserti-Gazdewich C, Lin Y.  Case Series: Bleeding complications from the direct oral anticoagulants. BMC Hemology; 2015; 15:18.
  40. St Bernard R, Yan M, Ning S, Escorcia A, Pendergrast J, Cserti-Gazdewich CM.  Sustained and Significant Increase in Reporting of Transfusion Reactions with the Implementation of an Electronic Reporting System.  Transfusion May 2016; 56(5):  1247-8.
  41. Tseng E, Spradbrow J, Cao X, Callum J, Lin Y. An order set and checklist improve physician transfusion ordering practices to mitigate the risk of transfusion-associated circulatory overload. Transfusion Medicine.  2016 Apr;26(2):104-10.
  42. Tong TN, Burke-Murphy E, Sakac D, Pendergrast J, Cserti-Gazdewich C, LaRoche V, Branch DR. Optimal Conditions for Performance of a Monocyte Monolayer Assay. Transfusion 2016 November; 56(11):  2680-2690.
  43. Tong T, Cserti-Gazdewich C, Branch DR.  MMA Crossmatch.  Transfusion Medicine, 2016 August; 26(4):301-2.
  44. Wilkenhorst D, Murphy M, Greinacher A, Shehata N, Bakchoul T, Massey E, Baker J, Lieberman L, Kjeldsen-Krach J, Oepkes D, Ryan G. Antenatal Management in Fetal and Neonatal Alloimmune Thrombocytopenia: A Systematic Review. Blood. 2017;129(11):1538-1547.

#Abstracts

  1. Vijenthira S, Armali C, Downie H, Wilson A, Paton K, Berry B, Cserti-Gazdewich C, Callum J. Registration Errors Among Patients Receiving Blood Transfusions: A National Analysis from 2008-2017. American Society of Hematology 61st Annual Meeting & Exposition, Orlando FL; ID 3689. December 7-10 2019, ID #3689.
  2. Acker JP, Hansen AL, Yi Q-L, Sondi N, Cserti-Gazdewich C, Pendergrast J, Hannach B.  Introduction of a Closed-System Cell Processor for Red Blood Cell Washing: Post-Implementation Monitoring of Safety and Efficacy. Canadian Society for Transfusion Medicine (CSTM) Annual Meeting, Winnipeg MB, May 1-4, 2015.
  3. Ahlin J, Coroneos M, Cserti-Gazdewich C, Pavenski K, Lin Y, Barrett J, Malinowski A, Shehata N.  The Effect of Red Cell Autoantibodies on Pregnancy Outcomes. American Association of Blood Banks (aaBB) Annual Meeting, Anaheim CA; October 23-27, 2015; ID 2304607, SP289;  Transfusion 2015; 55S3: 173A.
  4. Bacchus F, Pendergrast J, Cserti C.  Fatal, Acute Hemolytic Transfusion Reaction: Real or Coincidence? Canadian Society of Transfusion Medicine Annual Meeting, Halifax NS, May 2012.
  5. Baweezer M, McFarlan A, Ahmed N, Pavenski K, Nathens A. 97% of massive transfusion protocol activations do not include a complete hemorrhage panel. The Trauma Association of Canada (TAC) Annual Meeting. Toronto, Ontario, Canada. Apr 2012.
  6. Bloch E, Sakac D, Pendergrast JM, Cserti-Gazdewich CM, Branch DR.  Immunoprotein Analysis: A New Tool for the Diagnosis of DAT Negative Autoimmune Hemolytic Anemia. Annual Meeting, Denver CO; Saturday October 12th 2013, Poster session (SP327), Transfusion 2013; 53S: 183A.
  7. Cserti-Gazdewich C, Mills M, Cardoso F, Marsell B, Fitzgibbon S, Balmer S, Pendergrast J, Kuo K, Ward R, Delabie J, Barth D.  Sickle Trait Testing of Donor Red Cell Units Allocated to Sickle Cell Recipients:  Costs and Yields in a Carte-Blanche Approach. Canadian Society of Transfusion Medicine (CSTM) Annual Meeting, Ottawa ON, Apr 20-23, 2017.
  8. Cserti-Gazdewich C, Escorcia A, Pendergrast J, Lieberman L, Lin Y, Callum J.  Making a TACO in a Downtown Hospital:  Where and with What?  Canadian Society of Transfusion Medicine (CSTM) Annual Meeting, Ottawa ON, Apr 20-23, 2017.
  9. Cserti-Gazdewich C, Callum J, Lin Y, Lima A, Pendergrast J, Lieberman L.  Identifying the target age for trials to test strategies to decrease the incidence of transfusion-associated circulatory overload (TACO). American Association of Blood Banks (aaBB) Annual Meeting, Orlando FL; October 22-25, 2016; ID 2533384, SP-353, Transfusion September 2016; 56(S4): 166A.
  10. Cserti-Gazdewich CM, Escorcia A, Tasmin F, Lima A, Pendergrast J, Lieberman L, Lin Y, Callum J. Feeling the Burn: The Significance of Febrile Non-Hemolytic Transfusion Reactions (FNHTR) at Two Institutions. American Association of Blood Banks (aaBB) Annual Meeting, Orlando FL; October 22-25, 2016; ID 2532033, SP-350,  Transfusion September 2016; 56(S4): 164A-165A.
  11. Cserti-Gazdewich CM, Lin Y, Lieberman LD, Callum J, Pendergrast J, Pavenski K, Lau W,  Skeate RC, Latour C, Shehata N.  Blood Use and Kell Seroconversion Mitigation Practices In Females Across Five Hospitals. American Association of Blood Banks (aaBB) Annual Meeting, Anaheim CA; October 23-27, 2015; ID 2304515, SP-288, Transfusion 2015; 55S3: 172-3A.
  12. Cserti-Gazdewich CM, Pendergrast J, Lin Y, Callum J, Lieberman L, Escorcia A, Ramirez-Arcos S.  Post-Transfusion Fevers and Post-Reaction Culture Practices at a Large Academic Hospital Transfusion Service:  Quality of Information and Calculated Bacterial Contamination Event Rates. American Society of Hematology (ASH) 57th Annual Meeting & Exposition, Orlando FL; ID 82166, December 4-8, 2015.
  13. Cserti-Gazdewich C, D’Onofrio L, Pendergrast J.  The Fluidic Angioplasty Theory in Transfusion-Associated Circulatory Overload (TACO) Events Marked By Fever:  Is It The Age of the Patient or the Age of the Product? Transfusion 2013; 53(s):136A.
  14. Cserti-Gazdewich C, Angers M, Niranjan A, Thorpe G, Beal J, Balmer S, Hawes J, Tsiokos E, Pendergrast J, Reis M. Adult Thalassemia Patients Are Not Disadvantaged By Matching Less Rigorously Than The Sickle Cell Standard. Canadian Society of Transfusion Medicine Annual Meeting, Edmonton AB, June 2013.
  15. Cserti-Gazdewich CM, Pendergrast J, Lin Y, Callum J, Shehata N, Pavenski K, Vietz C, Ochoa G, Reis M.    The Adoption of Selective External Reference Laboratory Red Cell Genotyping by a Multi-Hospital Transfusion Medicine Collaborative: Costs, Volumes, Applications, and Findings. Transfusion 2012; 52S: 153A.
  16. Escorcia A, Tasmin F, Dharman A, Lieberman L, Cserti-Gazdewich C, Pendergrast J. Consent to Blood Transfusion: Recalling the Discussion. Canadian Society of Transfusion Medicine (CSTM) Annual Meeting, Ottawa ON, Apr 20-23, 2017.
  17. Escorcia A, Tasmin F, D’Onofrio L, Beal J, Thorpe G, Balmer S, Callum J, Lin Y, Lieberman L,Pendergrast J, Cserti-Gazdewich C.  How Long To Detain a Transfusee?  Hemovigilance Data To Guide Post-Administration Observation Duration Policies. Canadian Society for Transfusion Medicine (CSTM) Annual Meeting, Winnipeg MB, May 1-4, 2015.
  18. Escorcia A, Tasmin F, Sondi N, Balmer S, Callum J, Lin Y, Lieberman L, Pendergrast J, Cserti-Gazdewich C.  The Significance of Chido/Rodgers Antibodies in Allergic Spectrum Transfusion Reactions.  Canadian Society for Transfusion Medicine (CSTM) Annual Meeting, Winnipeg MB, May 1-4, 2015.
  19. Kanfar S, Pendergrast J, Lipton J, Cserti-Gazdewich C.  Successful Allogeneic Bone Marrow Transplantation in Acute Myeloid Leukemia with incidental Resolution of Concomitant Celiac Disease, IgA Deficiency, and HLA-Alloimmune Platelet Refractoriness. Canadian Society of Transfusion Medicine (CSTM) Annual Meeting, Vancouver BC, May 11-15, 2016.
  20. Kjaer M, Bertrand G, Bakhoul T, Massey E, Baker J, Lieberman L, Tanael S, Greinacher A, Murphy M, Arnold D, Baidya S, Bussel J,Kaplan C, Oepkes D, Ryan G, Shehata N, Kjeldsen-Kragn J.The detection of maternal HPA-1a antibodies and their role in predicting the severity of FNAIT: a systematic review. International Society of Blood Transfusion Coppenhagen, Denmark. June 20, 2017
  21. Kopolovic I, Ostro J, Cserti-Gazdewich C, Dzik WH, Tsubota H, Keir A, Messner HA, denHollander N, Lin Y, Callum J. Product Attributes and Donor Factors in Reported Cases of Transfusion-Associated Graft Versus Host Disease: A Systematic Review.  American Society of Hematology (ASH) 56th Annual Meeting & Exposition, Blood 2014: abstract 2883, 401. Basic Science & Clinical Practice in Blood Transfusion: Poster II, West building, Level 1 (Moscone), San Francisco, CA; Sunday December 7th 2014, 6-8 pm.
  22. Kou Y, Loza-Correa M, Taha M, Kalab M, Ronholm J, Schlievert PM, Cahill MP,  Skeate R, Cserti-Gazdewich C, Ramirez-Arcos S.  False negative septic transfusion case caused by a platelet pool showing visible clotting due to contamination with Staphylococcus aureus. Canadian Society of Transfusion Medicine (CSTM) Annual Meeting, Ottawa ON, Apr 20-23, 2017.
  23. Krok E, Pape, A, Hartill-Dadson, K, Matukas, L, Pavenski, K. Patient Identification Audit. Canadian Society for Transfusion Medicine (CSTM) Annual Meeting, Winnipeg MB, May 1-4, 2015.
  24. Lau W, Sumner C, Oldfield L, Hawes J, Cserti-Gazdewich C.  Anti-Sc2 of the Scianna Blood Group System can cause hemolytic transfusion reactions: Serendipity confirms clinical significance.  American Association of Blood Banks (aaBB) Annual Meeting, Orlando FL; October 22-25, 2016; ID 2533087, SP-274, Transfusion September 2016; 56(S4): 139A-140A
  25. Lieberman L, Betcherman L, Sung L, Pole J, Escourt L, Stanworth S. Incidence of Intracranial Haemorrhage In Paediatric Oncology Patients. American Association of Blood Banks Annual Conference, Orlando, Florida; Oct 22 2016.
  26. Lieberman L, Barty R, Liu Y, Portwine C, Heddle N.  An Epidemiological Cohort Study of Blood Transfusion Practices Among a Population of Pediatric Oncology Patients. American Association of Blood Banks, Boston, Massachusetts, Mar 2015.
  27. Lieberman L, Maskens C, Cserti-Gazdewich CM, Hansen M, Lin Y, Pendergrast J, Yi QL, Callum J.  A retrospective review of patient factors, transfusion practices, and outcomes in patients with TACO. Transfusion 2013; 53(2S):53A.
  28. Lieberman L, Hannach B, Petraszko T   Skeate B.  Does TRALI occur in children? Canadian case series and review of the literature. 14th International Hemovigilance Seminar, Montreal, Quebec, Canada April 2012.
  29. Lieberman L, Hannach B, Petraszko T,  Skeate B. Pediatric transfusion related acute lung injury: A case series and review of the literature. Canadian Society of Transfusion Medicine Annual Conference, Halifax, Nova Scotia, Canada; May 2012.
  30. Lin Y, Cohen R, Parmar N, Armali C, Callum J, Cserti-Gazdewich C, Lieberman L, Pendergrast J.  TACO Prevention: How Commonly are Diuretics Prescribed? Canadian Society of Transfusion Medicine (CSTM) Annual Meeting, Ottawa ON, Apr 20-23, 2017.
  31. Michelis FV, Branch DR, Scovell I, Pendergrast J, Lipton JH, Cserti-Gazdewich CM. Severe Acute Hemolysis With Passive Anti-A From IVIG Administered For ITP In A Bone Marrow Transplant Patient Exhibiting Graft-Source Group A Erythropoieisis And Host Group O Secretor Status. Transfusion 2012; 52S: 136A.
  32. Ostro J, Kopolovic I, Lin Y, Dzik WH, Cserti-Gazdewich C, Tsubota H, Keir A, Messner HA, DenHollander N, Callum J.  Systematic Review of Cases of Transfusion Associated Graft-Versus-Host-Disease (TA-GVHD): Analysis of Patient Characteristics and Outcomes.  American Society of Hematology (ASH) 56th Annual Meeting & Exposition, Blood 2014: abstract 2885, 401. Basic Science & Clinical Practice in Blood Transfusion: Poster II, West building, Level 1 (Moscone), San Francisco, CA; Sunday December 7th 2014, 6-8 pm.
  33. Pigeau S, Cote J, Cserti-Gazdewich C, Richards R, Scalia V, Berardi P.  Novel Silencing JR/ABCG2 Alleles Resulting in a Jr(a-) Phenotype. Canadian Society of Transfusion Medicine (CSTM) Annual Meeting, Ottawa ON, Apr 20-23, 2017.
  34. Richards L, Skinner I, Lieberman L, Lin Y, Callum J, Pendergrast J, Cserti-Gazdewich C.  Before and After the Gate:  Enhancing Detection of Alloimmunizable RHD Types in Child Bearing Age Females. Canadian Society of Transfusion Medicine (CSTM) Annual Meeting, Ottawa ON, Apr 20-23, 2017.
  35. Richards L, Skinner I, Lupish A, Johnston G, Balmer S, Lieberman L, Lin Y, Callum J, Pendergrast J, Cserti-Gazdewich C.  When is a Positive Truly So?  Defining a New Cut-Off in a Precautionary Approach to D Typing in Child-Bearing Age Female Individuals. Canadian Society of Transfusion Medicine (CSTM) Annual Meeting, Vancouver BC, May 11-15, 2016.  Transfusion Medicine Reviews 2016; 30: 147. http://dx.doi.org/10.1016/j.tmrv.2016.05.006
  36. Skeate R, Ramirez-Arcos S, Cserti-Gazdewich C, D’Onofrio L, Huang M, Mazzulli T. Septic Transfusion Reaction due to Staphylococcus aureus Contamination in One of Two Units from a Split Apheresis Platelet Donation.  Canadian Society of Transfusion Medicine Annual Meeting, Halifax NS, May 2012.
  37. Tsui H, Pendergrast J, Cserti-Gazdewich CM.  Flow cytometric analysis of an atypical case of Transfusion-Association Lymphocytosis (TAL).  American Association of Blood Banks (aaBB), Annual Meeting, Philadelphia PA; Saturday October 25th 2014, control ID 2001125, Poster session (SP218), Transfusion 2014; 54S: 143A.
  38. Tsui H, Pendergrast J, Cserti-Gazdewich CM. Transfusion Support of Combination ABO Mismatched Chimeric Bone Marrow and Solid Organ Transplant Recipients: A Practical Approach to ABO Designation and Product Selection. American Association of Blood Banks (aaBB), Annual Meeting, Philadelphia PA; Saturday October 25th 2014, control ID 2006832, Poster session (SP74), Transfusion 2014; 54S: 67A.
  39. Tsui H, Hawes J, Pendergrast J, Cserti-Gazdewich C. A Method Dependent Anti-Jka Delayed Serologic Transfusion Reaction.  Canadian Society of Transfusion Medicine Annual Meeting, Edmonton AB, June 2013.
  40. Yan M, Cserti-Gazdewich C.  Inpatient Non-Hemolytic Delayed Serologic Transfusion Reactions and Hospital Length of Stay: Is There an Association?  American Society of Hematology (ASH) 58th Annual Meeting & Exposition, San Diego CA; December 2-6, 2016
  41. Yan M, Marsell B, Cserti-Gazdewich C. Incidence of Post-Transfusion Screen-Positivity In Pre-Transfusion Screen-Negative Patients by Disease Population. Canadian Society of Transfusion Medicine (CSTM) Annual Meeting, Vancouver BC, May 11-15, 2016.

#Grants

  1. 2015. Principal Investigator: Pre-transfusion furosemide in patients at high-risk of transfusion-associated circulatory overload: A pilot randomized trial (TACO-BEL Trial). University of Toronto, Department of Medicine Yeo Chair Grant in Benign Hematology. PI: Callum J. Collaborator(s): Pendergrast J, Lieberman L, Cserti-Gazdewich C, Lin Y. 19, 200 CAD [Grants]
  2. 2015. Principal Investigator. Incidence of Intracranial Hemorrhage in Pediatric Oncology Patients. Canadian Blood Services, Small Projects Grant. PI: Lieberman L. Collaborator(s): Escourt L, Stanworth S, Pole J, Sung L. 15,000 CAD [Grants]
  3. 2015. Principal Investigator. Incidence of Intracranial Hemorrhage in Pediatric Oncology Patients. Heart and Stroke Foundation of Ontario (The) (HSFO) Comprehensive Research Experience for Medical Students. PI: Lieberman L Collaborator(s) Pole J, Escourt L, Stanworth S. 2,800 CAD [Grants]
  4. 2015. Principal Investigator. Pre-transfusion Furosemide for TACO.  Canadian Blood Services Small Projects Fund - November 2015 Competition. PI:  Skeate R. Collaborator(s) Callum J, Cserti-Gazdewich C, Hansen M, Lieberman L, Lin Y, Pendergrast J, Scales D.  15,000 CAD. [Grants]
  5. 2015. Principal Investigator. Safety of Lumbar Punctures in Patients with Thrombocytopenia. Alexandra Yeo Funds. 2015 CREMS Summer Program. PI: Lin Y. Collaborator(s): Kerbel B, Ning S. 2,750 CAD [Grants]
  6. 2015. Co-Investigator. An Observational Multicenter Cohort Study on Efficacy and Safety of Unactivated Prothrombin Complex Concentrate for Reversal of Oral, Direct Factor Xa Inhibitors Rivaroxaban or Apixaban in Treatment of Major Bleeding Events (UPRATE). PI: Schulman S. Collaborator(s) Lieberman L, Gross P, Ritchie B, Nahirniak S, Lin Y, Carrier M, Crowther M, Ghosh I, Lazo-Langner A, Zondang M. Octapharma sponsored study. 62,350 [Grants]
  7. 2014. Principal Investigator. Elucidation of the mechanism of IVIG associated hemolysis. Canadian Blood Services and Health Canada. Intramural grants competition. PI: Branch D. Collaborator(s): Pendergrast J, Shehata N, Callum J, Cserti C, Lin Y, Pavenksi K, Lieberman L. 393,712 CAD. [Grants]
  8. 2013. Principal Investigator. The Use of Gel column Agglutination Compared to Hemagglutination (tube) for Prenatal Antibody Titration for D, c and Kell Antigens. Ortho Biotech Inc. PI: Shehata N. Collaborator(s): Lin Y, Callum J. 18,625 CAD. [Industrial Grants]
  9. 2013. Co-Investigator. A randomized controlled trial of pre-operative treatment with ferrous fumarate 300mg once daily versus placebo in newly diagnosed gynecologic oncology patients who are primary surgical candidates. Sunnybrook Health Sciences Centre (Toronto, ON). Sunnybrook AFP Innovation Fund. PI: Vicus D. Collaborator(s): Callum J, Lin Y, Pasetka M. 72,762 CAD [Grants]

#Impacts

  1. Policy - Transfusion Reaction Policy 2014-2016. University Health Network, Sunnybrook Health Sciences Centre, Lakeridge Health (4 hospital sites), Sault Area Hospital, Timmins District and Hospital (11 associated hospital sites), Weeneybayko Area Health Authority.
  2. Policy – TACO prevention policy 2016. Sunnybrook Health Sciences Centre.
  3. Policy – Serology re-investigation policy 2016. University Health Network, Lakeridge Health (4 hospital sites), Sault Area Hospital, Timmins District and Hospital (11 associated hospital sites), Weeneybayko Area Health Authority.
Buy now